Stories from MedEsthetics
Thursday, August 24, 2017 - 09:29
In an effort to help patient’s understand the relative risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), authors of a study published in the September 2017 issue of Aesthetic Surgery performed a micromort analysis, which measures relative risk of activities and exposures.
Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
Thursday, August 17, 2017 - 14:12
A review study published in the September 2017 issue of the Journal of the American Academy of Dermatology supports the role of Demodex mites in rosacea. Ying Shuo-Chang, MD, and Yu-Chen Huang, MD, of Taipei Medical University Hospital, Taiwan, performed a literature search in PubMed, MEDLINE, and EmBase databases from inception through October 31, 2016. They searched the terms “Demodex” and “Demodex Mites” combined with “Rosacea.” All studies included in their review and meta-analysis were human clinical trials published in English.
Thursday, August 17, 2017 - 14:10
Aesthetic laser and light system manufacturer Sciton is celebrating is celebrating its 20-year anniversary this year with a limited-time website and a two-day User Summit scheduled for November 11-12, 2017. The new Sciton website offers a brief history of the company’s product development, physician testimonials, and profiles of long-term employees.
Thursday, August 17, 2017 - 14:08
An experimental device that offers multiple tunable wavelengths—the TRASER (Total Reflection Amplification of Spontaneous Emission Radiation)—is safe and effective in the treatment of nasal telangiectasias, according to a study published in Lasers in Surgery and Medicine (August 2017).
Thursday, August 10, 2017 - 11:49
Larry Brilliant, MD, MPH, will deliver the opening keynote address at the 2017 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) on October 5 in Chicago.
Thursday, August 10, 2017 - 11:00
Bonti, a clinical-stage biotechnology company, has announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profile, characterized by fast onset of action (about 24 hours) and short duration of effect (about 4 weeks).
Thursday, August 10, 2017 - 10:56
The American Society for Laser Medicine & Surgery (ASLMS) is hosting its 8th Annual Laser Aesthetics Course October 28-29, 2017, at the Beckman Laser Institute in Irvine, California.
Thursday, August 10, 2017 - 10:48
Practices can save money and downtime by considering future needs as they investigate IT options.By David J. WaldronTechnology plays an integral role in healthcare today. Not only have electronic medical records (EMR) become the law of the land, but practices also benefit from the use of practice management software and integrated systems that offer online booking, lead tracking and social media management. Implementing EMR and practice management systems involves a number of challenges in that they are costly, they evolve rapidly and they can quickly become obsolete. Therefore, it is...
Thursday, August 3, 2017 - 12:34
Valeant is rebranding its dermatology products under the name Ortho Dermatologics, which was acquired by Valeant in 2011. The rebranding coincides with the company’s launch of SILIQ, a biologic drug approved for the treatment of psoriasis. “The branding under Ortho Dermatologics allows us to showcase what we have as a company,” says William (Bill) Humphries, executive vice president of dermatology at Valeant. “We have more than 100 years of dermatology experience on the team now and we have a portfolio of dermatology products that, I think, is unrivaled in the industry.”
Thursday, August 3, 2017 - 12:31
In July, Ohio became the seventh state to pass SUNucate legislation, a nationwide effort led by the American Society for Dermatologic Surgery Association (ASDSA). The law eliminates barriers prohibiting students from possessing and using over-the-counter sunscreen by exempting these products from ”medication bans” in schools that require a physician’s note or prescription. In addition to Ohio, Alabama, Arizona, Florida, Louisiana, Utah and Washington state have also approved similar measures this year.
Thursday, August 3, 2017 - 12:28
Ideal Implant, founded in 2006 to develop, manufacture and market the saline IDEAL IMPLANT Structured Breast Implant has appointed Paul Herchman, co-founder and former CEO of ThermiGen, to its board of directors. He will act as a consultant in corporate development. Current board member Kevin Morano will assume the role of chief financial officer, continuing to lead the company's financial strategy, and Gabe Walters has been promoted from national sales director to vice president of U.S. sales.
Thursday, August 3, 2017 - 12:26
Two small-scale studies highlight the potential of silver particles to improve the efficacy of laser hair removal and light-based acne treatments.By Inga HansenAs aesthetic treatments become more varied and efficacious, there remain some key gaps in treatment options. For example, laser hair removal is one of the most popular services offered in aesthetic practices and medspas, yet permanent hair reduction is not an option for those with blonde and red hair. Dermatologists have long sought an alternative to systemic treatments for those with moderate-to-severe acne, and while laser...
Thursday, July 27, 2017 - 12:55
Medical aesthetics company Sientra has acquired Miramar Labs for $20 million in upfront cash, plus contractual rights for potential contingent payments of up to $14 million in cash upon the achievement of certain milestones. The acquisition brings the miraDry system, the only FDA-cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors, to Sientra’s product portfolio.
Thursday, July 27, 2017 - 12:51
Allergan has acquired the Regenica growth factor-based skincare line, and will market the line’s proprietary multipotent cell-conditioned media, which was developed by regenerative medicine company Histogen. Allergan plans to incorporate the technology, known as Multipotent Resignaling Complex (MRCx), in future products under the SkinMedica portfolio.
Thursday, July 27, 2017 - 12:48
Sebacia announced that it has completed a $20 million Series D financing to complete a U.S. pivotal trial of its proprietary microparticle treatment for moderate to severe acne.
Thursday, July 27, 2017 - 12:44
Physicians share their most popular and effective combination treatment regimens.By Inga HansenPatients seeking skin rejuvenation procedures typically present with a variety of concerns ranging from skin laxity to brown spots, visible vascularity, and fine lines and wrinkles. Delivering optimal outcomes often requires the use of multiple treatment modalities. This has led physicians to embrace combination treatments that enable them to treat several signs of aging in one treatment session, saving patients both time and money.
Thursday, July 20, 2017 - 12:04
Absorbable facial suspension sutures made of poly-l-actic acid (PLLA) and poly-lactide-co-glycolide (PGLA) offer benefits to patients with moderate facial aging who require more correction than can be achieved with injectable soft tissue fillers, according to an evidence review of suture lift technologies published in the Journal of Drugs in Dermatology (July 2017).